BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 24969351)

  • 1. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
    Xu SH; Yang YL; Han SM; Wu ZH
    World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
    Wang G; Shen N; Cheng L; Lin J; Li K
    Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
    Li RZ; Wang LM
    World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
    Wang Z; Cai H; Lin L; Tang M; Cai H
    Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
    Li X; Yang H; Tian Q; Liu Y; Weng Y
    Neoplasma; 2014; 61(4):453-60. PubMed ID: 24645838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
    Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
    Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-21 predicts poor prognosis in patients with osteosarcoma.
    Ren X; Shen Y; Zheng S; Liu J; Jiang X
    Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
    Mu Y; Zhang H; Che L; Li K
    Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
    Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
    Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
    Zou P; Ding J; Fu S
    Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma.
    Lian D; Wang ZZ; Liu NS
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1258-62. PubMed ID: 27097944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
    Zhang C; Yao C; Li H; Wang G; He X
    Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma.
    Taheriazam A; Talaei AJ; Jamshidi M; Shakeri M; Khoshbakht S; Yahaghi E; Shokrani M
    Diagn Pathol; 2015 Oct; 10():184. PubMed ID: 26446495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q; Song S; Ni G; Li Y; Wang X
    Cancer Biomark; 2018 Feb; 21(3):521-526. PubMed ID: 29103020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
    Hong Q; Fang J; Pang Y; Zheng J
    Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
    Chen K; Pan G
    Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-199b-5p promotes malignant progression of osteosarcoma by regulating HER2.
    Chen Z; Zhao G; Zhang Y; Ma Y; Ding Y; Xu N
    J BUON; 2018; 23(6):1816-1824. PubMed ID: 30610808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma.
    Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y
    J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.